HLA-Encoded Genetic Predisposition in IDDM: DR4 Subtypes May Be Associated With Different Degrees of Protection

Recent studies have shown that the risk conferred by the high-risk DQAl*03-DQBl*0302 (DQ8) haplotype is modified by the DRB1*O4 allele that is also carried by this haplotype. However, many of these studies suffer from lack of sufficient numbers of DQ-matched control subjects, which are necessary because there is a strong linkage disequilibrium between genes in the HLA complex. In the present study, using a large material of IDDM patients and DQ-matched control subjects, we have addressed the contribution of DR4 subtypes to IDDM susceptibility. Our data, together with recent data from others, clearly demonstrate that some DR4-DQ8 haplotypes are associated with disease susceptibility, while others are associated with protection, depending on the DRB1*O4 allele carried by the same haplotype. In particular, our data demonstrate that DRBl*0401 confers a higher risk than DRBl*0404. Based on combined available data on the genetic susceptibility encoded by various DR4-DQ8 haplotypes and the amino acid composition of the involved DRβ*04 chains as well as the ligand motifs for these DR4 subtypes, we have developed a unifying hypothesis explaining the different risks associated with different DR4-DQ8 haplotypes. We suggest that disease susceptibility is mainly conferred by DQ8 while DR4 subtypes confer different degrees of protection. Some DR4 subtypes (i.e., DRB1*0405, 0402, and 0401) confer little or no protection, while others (i.e., DRB 1*0404, 0403, and 0406) cause an increasing degree of protection, possibly by binding a common protective peptide. Features of a protective peptide that fit such a model are briefly discussed.

[1]  V. Gnau,et al.  Natural ligand motifs of closely related HLA-DR4 molecules predict features of rheumatoid arthritis associated peptides. , 1996, Biochimica et biophysica acta.

[2]  T. Sasazuki,et al.  Different contribution of HLA-DR and -DQ genes in susceptibility and resistance to insulin-dependent diabetes mellitus (IDDM). , 1996, Tissue antigens.

[3]  R. Karr,et al.  Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[4]  F. Cucca,et al.  The distribution of DR4 haplotypes in Sardinia suggests a primary association of type I diabetes with DRB1 and DQB1 loci. , 1995, Human immunology.

[5]  H. Heimberg,et al.  DRB1*0403 protects against IDDM in Caucasians with the high-risk heterozygous DQA1*0301-DQB1*0302/DQA1*0501-DQB1*0201 genotype. Belgian Diabetes Registry. , 1995, Diabetes.

[6]  J. Strominger,et al.  Selective binding of self peptides to disease-associated major histocompatibility complex (MHC) molecules: a mechanism for MHC-linked susceptibility to human autoimmune diseases , 1995, The Journal of experimental medicine.

[7]  R. Karr,et al.  Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association , 1995, The Journal of experimental medicine.

[8]  Z. Nagy,et al.  Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning , 1994, The Journal of experimental medicine.

[9]  J. Todd,et al.  A genome-wide search for human type 1 diabetes susceptibility genes , 1994, Nature.

[10]  A. Børresen,et al.  DQA1 and DQB1 genes in patients with squamous cell carcinoma of the cervix: relationship to human papillomavirus infection and prognosis. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[11]  S. Matsushita,et al.  Allele specificity of structural requirement for peptides bound to HLA- DRB1*0405 and -DRB1*0406 complexes: implication for the HLA-associated susceptibility to methimazole-induced insulin autoimmune syndrome , 1994, The Journal of experimental medicine.

[12]  J. Ilonen,et al.  The case for elimination of cow's milk in early infancy in the prevention of type 1 diabetes: the Finnish experience. , 1993, Diabetes/metabolism reviews.

[13]  Henry A. Erlich,et al.  HLA class II alleles and susceptibility and resistance to insulin dependent diabetes mellitus in Mexican-American families , 1993, Nature Genetics.

[14]  E. Thorsby,et al.  HLA matching of unrelated bone marrow transplant pairs: direct sequencing of in vitro amplified HLA-DRB1 and -DQB1 genes using magnetic beads as solid support. , 1993, Tissue antigens.

[15]  G. Thomson,et al.  Homozygous parent affected sib pair method for detecting disease predisposing variants: Application to insulin dependent diabetes mellitus , 1993, Genetic epidemiology.

[16]  C. Boitard,et al.  Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus. , 1992, The Journal of clinical investigation.

[17]  M. Sheehy.  HLA and Insulin-Dependent Diabetes. A protective perspective , 1992, Diabetes.

[18]  E. Thorsby,et al.  Distribution of HLA class II alleles among Norwegian Caucasians. , 1990, Human immunology.

[19]  J. R. Rowe,et al.  A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles. , 1989, The Journal of clinical investigation.

[20]  D. Monos,et al.  Analysis of DR and DQ gene products of the DR4 haplotype in patients with IDDM: possible involvement of more than one locus. , 1988, Human immunology.

[21]  J. R. Rowe,et al.  T-cell-defined DR4 subtypes as markers for type 1 diabetes. , 1988, Human Immunology.

[22]  P. Terasaki,et al.  The Data and Statistical Analysis , 1985 .

[23]  K. Gabbay,et al.  Extended major histocompatibility complex haplotypes in type I diabetes mellitus. , 1984, The Journal of clinical investigation.

[24]  P. A. Peterson,et al.  HLA-D region β-chain DNA endonuclease fragments differ between HLA-DR identical healthy and insulin-dependent diabetic individuals , 1983, Nature.

[25]  A. J. Davis,et al.  HLA-D–related (DRw) Antigens in Juvenile Diabetes Mellitus , 1979, Diabetes.

[26]  D. Singal,et al.  Juvenile-onset Diabetes: HLA-A, -B, -C, and -DR Alloantigens , 1978, Diabetes.

[27]  R. Neutra,et al.  Estimating exposure-specific disease rates from case-control studies using Bayes' theorem. , 1978, American journal of epidemiology.

[28]  J. Nerup,et al.  HL-A antigens and diabetes mellitus. , 1974, Lancet.

[29]  M. Blajchman,et al.  Histocompatibility (HL-A) Antigens, Lymphocytotoxic Antibodies and Tissue Antibodies in Patients with Diabetes Mellitus , 1973, Diabetes.